Tenaya Therapeutics (TNYA) Change in Acquisitions & Divestments (2022 - 2025)

Tenaya Therapeutics' Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $34.8 million for Q4 2025.

• On a quarterly basis, Change in Acquisitions & Divestments rose 318.04% year-over-year to $34.8 million in Q4 2025; TTM through Mar 2026 was $34.0 million, a 53.54% decrease from a year earlier, with the FY2025 full-year figure at $45.7 million, down 43.67% from the prior year.
• Change in Acquisitions & Divestments improved to $34.8 million in Q4 2025 per TNYA's latest filing, from -$769000.0 in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $78.7 million in Q3 2022 and bottomed at -$769000.0 in Q2 2025.
• The 4-year median for Change in Acquisitions & Divestments is $32.5 million (2024), against an average of $31.9 million.
• Across the five-year window, Change in Acquisitions & Divestments surged 630.55% in 2024 and tumbled 102.37% in 2025, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $38.5 million in 2022, then slumped by 97.04% to $1.1 million in 2023, then jumped by 630.55% to $8.3 million in 2024, then soared by 318.04% to $34.8 million in 2025.
• Per Business Quant, the three latest TNYA Change in Acquisitions & Divestments figures stand at $34.8 million (Q4 2025), -$769000.0 (Q2 2025), and $11.7 million (Q1 2025).